Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?
Geoffrey L. Uy, Daniel J. DeAngelo, Jay N. Lozier, Dennis M. Fisher, Brian A. Jonas, John L. Magnani, Pamela S. Becker, Hillard M. Lazarus, Ingrid G. Winkler
Research output: Contribution to journal › Review article › peer-review
Fingerprint
Dive into the research topics of 'Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?'. Together they form a unique fingerprint.